𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas

✍ Scribed by Thornber, K; Colomba, A; Ceccato, L; Delsol, G; Payrastre, B; Gaits-Iacovoni, F

Book ID
109970924
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
307 KB
Volume
28
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Analysis of gene expression profile of T
Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma
✍ Sandra D. Bohling; Stephen D. Jenson; David K. Crockett; Jonathan A. Schumacher; πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 986 KB

Anaplastic large cell lymphoma (ALCL) comprises a group of non-Hodgkin lymphomas characterized by the expression of the CD30/Ki-1 antigen. A subset of ALCL is characterized by chromosomal translocations involving the anaplastic lymphoma kinase (ALK) gene on chromosome 2. While the most common transl

CD30 and the NPM-ALK fusion protein (p80
CD30 and the NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma
✍ Norihiro Awaya; Shigehisa Mori; Hitoshi Takeuchi; Shigeo Mori; Yasuo Sugano; Tam πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 2 views

## Abstract The t(2;5)(p23;q35) translocation results in the formation of a unique chimeric NPM‐ALK protein (p80). Expression of this protein is considered to be one of the clinical features of anaplastic large cell lymphoma (ALCL). Recently recognized as one clinical subtype of ALCL, the small cel